Global Cosmetic Surgery and Procedures Market to 2027 –

0

Dublin, June 06, 2022 (GLOBE NEWSWIRE) — The “Global Cosmetic Surgery and Procedures Market Size, Share and Trend Analysis Report by Procedure Type, by Non-Invasive Type, by Invasive Type, by Regional Outlook and Forecast, 2021-2027” report has been added to from ResearchAndMarkets.com offer.

The global cosmetic surgery and procedures market size is expected to reach USD 107.2 billion by 2027, with the market growing at 9.8% CAGR during the forecast period.

Cosmetic surgery is a specialized area of ​​medicine that focuses on improving one’s appearance through surgical and medicinal methods. All sections of the head, neck and body can benefit from cosmetic surgery. Also, cosmetic surgery is chosen by people who want to increase the aesthetic appeal of a functional part of the body.

The invention of new cosmetic devices by manufacturers has led to an increase in the demand for cosmetic therapies in recent years. The overview of technologically enhanced product lines, such as non-invasive body contouring systems that use fat freezing technology, for example, should generate lucrative growth opportunities.

Botulinum toxin is a naturally occurring deadly toxic substance with various applications. This toxin is most commonly used for the treatment of painful muscle spasms as well as for cosmetic reasons. Botulinum toxin is also known as Botox and Dysport. Small use of this toxic chemical helps in muscle coordination and this substance is very useful in cosmetic treatments.

Botox injections are known for their ability to degrade the appearance of facial folds. These injections are also used to treat excessive sweating (hyperhidrosis), neck spasms (cervical dystonia), an overactive bladder, and lazy eyes. Botox injections can also be helpful in preventing chronic migraines. Additionally, Botox injections temporarily paralyze the muscles by injecting a toxic substance onobotulinumtoxinA. This toxin is made by the microbiota responsible for botulism, which is a form of food poisoning. Botulinum toxin was first used in a medicine called Botox. AbbotulinumtoxinA (Dysport), rimabotulinumtoxinB (Myobloc) and incobotulinumtoxinA are now among the other products available (Xeomin). These injections are not interchangeable as they differ slightly, especially in terms of dosage units.

Along with this, Botox injections block the effects of particular chemical transmission of nerves, most of which end up causing muscles to contract. The most common use of these injections is to partially rest the facial muscles which eventually cause fine lines on the forehead and across the eyes. These injections are used to treat problems that affect body systems.

Plastic surgery is performed using a variety of instruments such as curettes, awls, gouges, scissors and mallets. According to their function, these instruments are classified as cutting tools, clamping or carrying instruments and pushers.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the demand for aesthetic medicine. Initially, social distancing and a sharp drop in consumer income hurt the entire cosmetic procedures industry. The market has witnessed a period of short-term negative growth due to factors such as temporary closures of beauty centers, limited operations, lower demand for products, and disruptions in the production and business chain.

Remote work improved the average time spent on Zoom calls. People pay too much attention to their physical appearance. It has created a market for cosmetic procedures, Botox being one of the most popular. Non-invasive procedures have grown in popularity in recent months, while invasive procedures have declined.

Market Drivers:

Increase in technological improvements and increase in demand for minimally invasive procedures

The market for cosmetic surgery and services is growing alongside technological advancements. This is due to better knowledge of advanced cosmetic surgery techniques and increased accessibility of beauty treatments. Technologies such as the Halo laser combine ablative and non-ablative wavelengths to benefit the skin on different levels.

Among the radio waves, the micro-needling devices are Secret, Infinite, Perennial, and Enzyme. With advances in technology and treatments, the demand for more effective cosmetic procedures is also increasing across the world. The cosmetic surgery industry and services are on the rise due to the growing preference for minimally invasive procedures.

Massive attention in modeling and a professional life in aviation

Several sectors, such as model making and aerospace, are integrally linked to human beauty seen from the outside. People seeking employment in these industries must meet certain beauty standards. Candidates applying for the position of flight attendant must meet airline requirements for height, skin color and body type.

When applicants have tattoos and piercings or scar tissue on their bodies, their applications are more often rejected. Participants who wish to pursue these career opportunities strive to meet the criteria. Many people are expected to prefer having cosmetic procedures, but the recovery time and chances of getting stitch scars during surgeries often prevent them from using it.

Marketing Restriction Factor:

Strict regulation and insufficient reimbursement

Restrictive laws and inappropriate reimbursement rates are two key factors expected to nullify the expansion of the Cosmetic Surgery and Services Market. Many patients do not seek a referral from their GP because they are extremely afraid of a nasty response or believe that plastic procedures are not primarily medical. Self-referral to the treatment center is a more appropriate option.

Aesthetic clinics have widely varying standards, but in response to an announcement, clinics frequently send representatives to the patient’s home. These lawmakers aren’t medically qualified, but they suggest surgeries and book surgery dates, often offering a discount if the doctor signs on right away.

Main topics covered:

Chapter 1. Market Scope and Methodology

Chapter 2. Market Overview
2.1 Presentation
2.1.1 Presentation
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market constraints

Chapter 3. Competitive Analysis – Global
3.1 Cardinal matrix of the editor
3.2 Recent Industry-Wide Strategic Developments
3.2.1 Partnerships, collaborations and agreements
3.2.2 Product launches and product extensions
3.2.3 Acquisitions and mergers
3.2.4 Approvals and tests
3.2.5 Geographic expansions
3.3 Main winning strategies
3.3.1 Key Primary Strategies: Percentage Breakdown (2017-2021)

Chapter 4. Global Cosmetic Surgery and Procedures Market by Procedure Type
4.1 Global Noninvasive Drugs Market by Region
4.2 Global Cosmetic Surgery and Procedures Market by Non-Invasive Type
4.2.1 Global Botox Injections Market by Region
4.2.2 Global Laser Hair Removal Market by Region
4.2.3 Global Soft Tissue Fillers Market by Region
4.2.4 Global Chemical Peel Market by Region
4.2.5 Global Microdermabrasion Market by Region
4.2.6 Global Others Market by Region
4.3 Global Invasive Market by Region
4.4 Global Cosmetic Surgery and Procedures Market by Invasive Type
4.4.1 Global Breast Augmentation Market by Region
4.4.2 Global Liposuction Market by Region
4.4.3 Global Nose Reshaping Market by Region
4.4.4 Global Abdominoplasty Market by Region
4.4.5 Global Eyelid Surgery Market by Region
4.4.6 Global Others Market by Region

Chapter 5. Global Cosmetic Surgery and Procedures Market by Region

Chapter 6. Business Profiles
6.1 Evolus, Inc. (Alphaeon Corporation)
6.1.1 Presentation of the company
6.1.2 Financial analysis
6.1.3 Research & Development costs
6.2 Revance Therapeutics, Inc.
6.2.1 Presentation of the company
6.2.2 Financial analysis
6.2.3 Segmental analysis
6.2.4 Research & Development expenses
6.3 Cynosure, LLC
6.3.1 Presentation of the company
6.3.2 Strategies and recent developments:
6.3.2.1 Acquisitions and Mergers:
6.3.2.2 Geographic extensions:
6.4 Alma Lasers Ltd. (Sisram Medical Ltd.)
6.4.1 Presentation of the company
6.4.2 Financial analysis
6.4.3 Regional Analysis
6.4.4 Research and development costs
6.4.5 Strategies and recent developments:
6.4.5.1 Product launches and product extensions:
6.4.5.2 Approvals and tests:
6.5 Candela Medical Corporation (Syneron Medical Ltd.)
6.5.1 Presentation of the company
6.5.2 Strategies and recent developments:
6.5.2.1 Acquisition and merger:
6.6 Bausch Health Companies, Inc.
6.6.1 Presentation of the company
6.6.2 Financial analysis
6.6.3 Sectoral and regional analysis
6.6.4 Research and development costs
6.7 Lumenis Ltd.
6.7.1 Presentation of the company
6.7.2 Strategies and recent developments:
6.7.2.1 Product launches and product extensions:
6.8 Galderma SA
6.8.1 Company overview
6.8.2 Strategies and recent developments:
6.8.2.1 Partnerships, collaborations and agreements:
6.8.2.2 Product launches and product extensions:
6.8.2.3 Acquisition and merger:
6.9 AbbVie, Inc. (Allergan PLC)
6.9.1 Company Overview
6.9.2 Financial analysis
6.9.3 Regional Analysis
6.9.4 Research and development costs
6.9.5 Strategies and recent developments:
6.9.5.1 Approvals and tests:
6.9.5.2 Acquisition and merger:

For more information on this report, visit https://www.researchandmarkets.com/r/oq9950


        
Share.

Comments are closed.